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Misfolding and aggregation of peptides and proteins is a
characteristic of many neurodegenerative disorders,
including Parkinson’s (PD) and Alzheimer’s disease (AD).
Their common feature is that normally unstructured and
soluble proteins misfold and aggregate into insoluble amy-
loid fibrils, which make up the deposits in the brains of
patients suffering from these devastating illnesses. A key
requirement to gain insight into molecular mechanisms of
disease and to progress in the search for therapeutic inter-
vention is a capability to image the aggregation process
and structure of ensuing fibrils in situ.
We have recently reported that amyloid proteins that are
associated with protein misfolding diseases, including PD,
AD and various other types of amyloidosis develop an
intrinsic fluorescence in the visible range [1,2]. The discov-
ery of intrinsic amyloid fluorescence has enabled the
process of amyloid formation from disease-relevant poly-
peptides to be monitored in a label-free manner and with
high specificity [2,3]. I will show here how specific and
sensitive in vivo probes of amyloid structures can be devel-
oped using external fluorophores covalently attached to
the amyloid backbone. Such external fluorophores can
participate in Förster resonance energy transfer (FRET)
with intrinsic energy states of amyloid structures if pre-
sent, providing a readout in the form of a reduced fluores-
cence lifetime of the external fluorophores. I will provide
an overview on the application of all-optical techniques to
inform on the aggregation state of a-synuclein (relevant to
PD), amyloid b and Tau (relevant to AD) in vitro, in live
cells and model organisms. Multiparametric microscopy
permits us to follow the kinetics of amyloid oligomerisa-
tion in vivo and correlate the appearance of aggregates
with phenotypes of disease [1]. Using direct stochastic
optical reconstruction microscopy, dSTORM, we are able
to probe, in cells, the morphology of the ensuing aggre-
gates with a resolution better than 20 nm [4]. We are able
to distinguish different types of structures, including oligo-
meric assemblies and mature fibrils, and observe a number
of morphological differences between the species formed
in vitro and in vivo, which may be significant in the con-
text of disease.
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